Compare MBOT & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBOT | ECBK |
|---|---|---|
| Founded | 2010 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.6M | 144.3M |
| IPO Year | 2000 | 2022 |
| Metric | MBOT | ECBK |
|---|---|---|
| Price | $2.12 | $18.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 10.1K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 60.27 | ★ 95.83 |
| EPS | N/A | ★ 0.94 |
| Revenue | $116,887.00 | ★ $598,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $119.77 | N/A |
| P/E Ratio | ★ N/A | $19.23 |
| Revenue Growth | N/A | ★ 3.64 |
| 52 Week Low | $1.60 | $14.83 |
| 52 Week High | $4.62 | $20.05 |
| Indicator | MBOT | ECBK |
|---|---|---|
| Relative Strength Index (RSI) | 40.05 | 56.60 |
| Support Level | $1.99 | $17.80 |
| Resistance Level | $2.22 | $18.70 |
| Average True Range (ATR) | 0.09 | 0.28 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 20.48 | 46.24 |
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.